Moderate riskFDA DeviceClass II

Medline Convenience Kits recalled for sterility breach risk in antiseptic applicators

Medline Convenience Kits containing BD ChloraPrep Clear and FREPP Clear applicators may have packaging defects—wrinkles in the paper lid that could compromise the sterile barrier. If the packaging is compromised, the sterile applicators inside could be exposed to microbial contamination before use.

From the FDA notice · Read the official notice ↗ · All Medline recalls

What to do

  1. Check your Medline Convenience Kit against the affected lot numbers listed in the FDA notice.
  2. Do not use affected kits. Contact your healthcare facility or Medline for instructions on return or disposal.
  3. If you have already used an affected kit, monitor the application site for signs of infection (redness, swelling, warmth, discharge) and report any concerns to your healthcare provider.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Medline Convenience Kits: 1) DYKM1414, Catalog Number: DYKM1414; 2) DYKM1414, Catalog Number: DYKM1414; 3) DYNDH1462A, Catalog Number: DYNDH1462A; 4) DYNJ38145F, Catalog Number: DYNJ38145F; 5) DYNJ63199A, Catalog Number: DYNJ63199A
Sold in
Nationwide
Made for
Adults

This recall covers 16 products — see all of them.

Details

Units affected
58037 kits
Illnesses reported
None reported
Manufactured in
3 Lakes Dr, N/A, Northfield, IL, United States
Classification
Class II
Recall number
Z-3050-2026

In the FDA's words

Description
Medline Convenience Kits: 1) DYKM1414, Catalog Number: DYKM1414; 2) DYKM1414, Catalog Number: DYKM1414; 3) DYNDH1462A, Catalog Number: DYNDH1462A; 4) DYNJ38145F, Catalog Number: DYNJ38145F; 5) DYNJ63199A, Catalog Number: DYNJ63199A The kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which have a potential breach of sterility in the packaging, due to wrinkles in the paper lidding which may extend to the seal area. If the sterile barrier is compromised, patients and users may be exposed to microbial contamination. Potential health consequences may include no injury, localized infection, or, less commonly, more serious infection requiring medical treatment, antimicrobial therapy, procedural intervention, or hospitalization. In rare cases, particularly in critically ill or immunocompromised patients, severe infection could become life-threatening. 1) DYKM1414, UDI-DI: 10889942481293(each), 40889942481294(case), Lot Number: 25BBB327; 2) DYKM1414, UDI-DI: 10889942481293(each), 40889942481294(case), Lot Number: 24KBE261; 3) DYNDH1462A, UDI-DI: 10193489993424(each), 40193489993425(case), Lot Number: 24ABC301; 4) DYNDH1462A, UDI-DI: 10193489993424(each), 40193489993425(case), Lot Number: 24ABT704; 5) DYNDH1462A, UDI-DI: 10193489993424(each), 40193489993425(case), Lot Number: 24BBO246; 6) DYNDH1462A, UDI-DI: 10193489993424(each), 40193489993425(case), Lot Number: 24BBU663; 7) DYNDH1462A, UDI-DI: 10193489993424(each), 40193489993425(case), Lot Number: 24CBJ141; 8) DYNDH1462A, UDI-DI: 10193489993424(each), 40193489993425(case), Lot Number: 23JBH263; 9) DYNDH1462A, UDI-DI: 10193489993424(each), 40193489993425(case), Lot Number: 23JBO539; 10) DYNDH1462A, UDI-DI: 10193489993424(each), 40193489993425(case), Lot Number: 23KBG333; 11) DYNDH1462A, UDI-DI: 10193489993424(each), 40193489993425(case), Lot Number: 23KBV434; 12) DYNDH1462A, UDI-DI: 10193489993424(each), 40193489993425(case), Lot Number: 23LBM123; 13) DYNJ38145F, UDI-DI: 10193489277173(each), 40193489277174(case), Lot Number: 25ABS139; 14) DYNJ38145F, UDI-DI: 10193489277173(each), 40193489277174(case), Lot Number: 24EBP237; 15) DYNJ38145F, UDI-DI: 10193489277173(each), 40193489277174(case), Lot Number: 24KBE336; 16) DYNJ38145F, UDI-DI: 10193489277173(each), 40193489277174(case), Lot Number: 23JBM582; 17) DYNJ38145F, UDI-DI: 10193489277173(each), 40193489277174(case), Lot Number: 23LBM892; 18) DYNJ63199A, UDI-DI: 10193489311730(each), 40193489311731(case), Lot Number: 24EBG970 Distribution: US Nationwide distribution. Affected quantity: 58037 kits
Hazard
The kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which have a potential breach of sterility in the packaging, due to wrinkles in the paper lidding which may extend to the seal area. If the sterile barrier is compromised, patients and users may be exposed to microbial contamination. Potential health consequences may include no injury, localized infection, or, less commonly, more serious infection requiring medical treatment, antimicrobial therapy, procedural intervention, or hospitalization. In rare cases, particularly in critically ill or immunocompromised patients, severe infection could become life-threatening.

16 products in this recall

Medline convenience kits recalled for possible sterility breach

Medline is recalling 16 convenience kit products that contain BD ChloraPrep Clear or FREPP Clear antiseptic applicators. Wrinkles in the paper lidding may extend to the seal, which could break the sterile packaging and allow microbial contamination. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

More from Medline

See all

Related topics